Drug

413 papers198 directions
Drug is a research venue focused on the intersection of pharmacology, drug development, and computational modeling. With a publication history spanning from 1973 to the present, the venue hosts a corpus of over 400 papers. Its scope encompasses a wide range of topics, including structure-based drug design, nanoscale delivery systems, and the evaluation of natural products. Research often centers on bridging the gap between in vitro models and in vivo applications, as well as addressing the preclinical translational gap in therapeutic development. In the context of machine learning and artificial intelligence, the venue publishes work on advanced computational representations for molecular geometry. This includes research into 3D geometric representations for molecular neural networks and Euclidean equivariant representations. These methods are applied to tasks such as modeling protein flexibility and decoding complex medicines through molecular docking and network pharmacology. Additionally, the venue features the application of natural language processing to clinical data, such as emergency department records for opioid poisoning surveillance. The venue also serves as a platform for clinical and pharmacokinetic research. It includes studies on dose proportionality in early-phase development, comparative pharmacokinetics, and Phase I dose-escalation trials. Notable research directions involve the study of cytochrome P450 splice variants and the development of next-generation drug conjugates for conditions like breast cancer. Prolific contributors to the venue include researchers such as Elizabeth Stuart, Yu Chen, and Dan Li, who contribute to its focus on both the mechanistic and translational aspects of pharmaceutical science.

Papers by Year

2026 5
2025 37
2024 35
2023 32
2022 30
2021 17
2020 23
2019 16
2018 21
2017 20
2016 15
2015 17
2014 21
2013 7
2012 6
2011 11
2010 12
2009 7
2008 14
2007 9
2006 4
2005 4
2004 3
2003 6
2002 6
2001 2
2000 2
1999 3
1998 1
1997 1
1996 3
1995 3
1994 2
1993 4
1992 4
1990 2
1989 1
1980 1
1975 3
1973 3

Top Research Directions

Research directions most represented by papers from this venue.

Microenvironment Triggered Cargo Release from Smart Nanocarriers 7
Overcoming Bioavailability Barriers for Poorly Soluble Compounds 6
Flattening the Pharmacokinetic Curve via Sustained Release Depots 4
Overcoming the Pharmacokinetic Characterization Gap 4
Predicting Ligand Protein Binding via Molecular Docking 4
Bridging the Cross Species Clinical Translation Gap 4
Ligand Mediated Active Targeting of Nanocarriers 3
Engineering Precision Vehicles for Targeted RNA Delivery 3
Closed-Loop Behavioral Nudging Through Real-Time Sensing 2
Scaling Chemical and Phenotypic Screens for Drug Discovery 2
Biogenic Synthesis of Biocompatible Functional Nanomaterials 2
Mechanisms of Metabolic Drug-Drug Interactions 2
Engineering Nanoparticle Size for Passive Tissue Targeting 2
The Preclinical Toxicity Assessment Gap 2
Competitive Interception of Viral Host Interactions 2

Top Authors

AuthorPapers
Elizabeth Stuart16
Shikhar Shrestha6
James R. Brown5
Lars Olsen4
W. Alex Mason4
Benjamin M. Marlin3
George Hripcsak3
Bilal Khan2
Bing He2
Günter Klambauer2
Jiang Bian2
Michael Habeck2
Sepp Hochreiter2
Thierry Langer2
Thomas Seidel2
Wei Wei2
Alan Aspuru-Guzik1
Alexander Baras1
Alfio Ferrara1
Ali Hojjat1

Impactful Papers

Papers from this venue that shaped research clusters.

Foundational

Influential

Related Venues

Venues with the most similar research cluster distributions.

Papers

TitleYear
Insights for the development of specific kinase inhibitors by targeted structural genomics2007
Interaction between buprenorphine and atazanavir or atazanavir/ritonavir2007
Intracellular Delivery of Nanogel-Quantum Dot Hybrid Nanoparticles into Human Periodontal Ligament Cells2007
Support vector machines approach for predicting druggable proteins: recent progress in its exploration and investigation of its usefulness2007
Taxane’s Substituents at C3′ Affect Its Regioselective Metabolism: Different in Vitro Metabolism of Cephalomannine and Paclitaxel2007
Analysis of complex, multidimensional datasets2006
Developing adaptive treatment strategies in substance abuse research2006
Enhancing the Bioavailability of Cyclosporine A Using Solid Dispersion Containing Polyoxyethylene (40) Stearate2006
Microarrays meet the Voltaire challenge: Drug discovery on a chip?2006
A computational view of microRNAs and their targets2005
Keynote review: Structural biology and drug discovery2005
Polyhedral Tools for Control2005
POSSIBLE PATHWAY(S) OF TESTOSTERONE EGRESS FROM THE ACTIVE SITE OF CYTOCHROME P450 2B1: A STEERED MOLECULAR DYNAMICS SIMULATION2005
An “Omics” view of drug development2004
Minimum information about a functional genomics experiment: the state of microarray standards and their extension to other technologies2004
Pharmacophore definition and 3D searches2004
Are PNAs a match for the BBB?2003
Drug Adverse Reaction Target Database (DART)2003
Internet resources for proteins associated with drug therapeutic effects, adverse reactions and ADME2003
Molecular analysis of antilipemic effects of FR218944, a novel vasopressin V1a receptor antagonist, in genetically diabetic db/db mice in comparison with pioglitazone and fenofibrate2003
Stop talking at the back2003
THE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVE2003
Contribution of CYP4A8 to the Formation of 20-Hydroxyeicosatetraenoic Acid from Arachidonic Acid in Rat Kidney2002
Effective Dosing Regimen of 1-Aminobenzotriazole for Inhibition of Antipyrine Clearance in Rats, Dogs, and Monkeys2002
Grid technologies empowering drug discovery2002
Model-based Analysis of the Pharmacokinetic Interactions Between Ritonavir, Nelfinavir, and Saquinavir after Simultaneous and Staggered Oral Administration2002
Promises of text processing: natural language processing meets AI2002
Safety Evaluation and Drug Development based on Biological Fate of Drugs —Efforts Made to Overcome Drug Interaction in Drug Development—2002
INCORPORATION OF ENDOCRINE DISRUPTION INTO CHEMICAL HAZARD SCORING FOR POLLUTION PREVENTION AND CURRENT LIST OF ENDOCRINE DISRUPTING CHEMICALS2001
Negative chronotropic effect of CVT‐510 in anesthetized and awake rats2001
Drug users' experiences of witnessing overdoses: what do they know and what do they need to know?2000
Use of non‐prescribed methadone and other illicit drugs during methadone maintenance treatment2000
Letter to the Editor1999
Multiple Cytochrome P-450s Involved in the Metabolism of Terbinafine Suggest a Limited Potential for Drug-Drug Interactions1999
The 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor Fluvastatin: Effect on Human Cytochrome P-450 and Implications for Metabolic Drug Interactions1999
Antibiotic discovery: is it all in the genes?1998
Evaluation of Intratumoral Injection of Poly(d,l-lactide) Cisplatin Microspheres in Rats with Breast Tumors Using [131I]lodomisonidazole (IMISO)1997
Cellular effects of antisensec-mycoligodeoxynucleotides are delivery dependent1996
Local perivascular administration of basic fibroblast growth factor: drug delivery and toxicological evaluation.1996
Molecular characterization of recombinant human adenosine receptors1996
In vitro studies to elucidate the metabolic pathway of (+)-S-145, a thromboxane A2 receptor antagonist, in rats. Evidence for two independent pathways in peroxisomal beta-oxidation.1995
Presystemic elimination of morphine in anesthetized rabbits. Contribution of the intestine, liver, and lungs.1995
Sites of biotransformation for the cyclosporin derivative SDZ IMM 125 using human liver and kidney slices and intestine. Comparison with rat liver slices and cyclosporin A metabolism.1995
ELUCIDATION OF METABOLIC PATHWAY OF THROMBOXANE A2 RECEPTORANT ANTAGONIST, (+)-S-145, IN RAT1994
The polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetron.1994
Drug policy: must we choose between harm minimization and abstinence?1993
Enantiomer-enantiomer interaction on N-monodemethylation of diuretic in rat liver microsomes.1993
Kinetic analysis of the reaction of melphalan with water, phosphate, and glutathione.1993
Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride.1993
Cyclosporin A metabolism in human liver, kidney, and intestine slices. Comparison to rat and dog slices and human cell lines.1992

« prev Page 8/9 next »